Press Releases

PORTLAND, Ore.--(BUSINESS WIRE)-- TransCore’s North American Freight index marked a record high for the month of January, up five percent compared to January 2011. Month-over-month, January’s spot market freight volume slipped eight percent compared to December. The month-over-month seasonal decline is consistent with historic trends but less than the prior ten year average decline of 14 percent.

TransCore’s monthly North American Freight Index reflects spot market freight availability on the company’s network of load boards in the United States and Canada.

Truckload freight rates increased 7.3 percent on the spot market for dry vans and 4.5 percent for flatbeds, compared to January 2011, while declining 0.7 percent for refrigerated (“reefer”) vans. The year-over-year rate increase in January continues the trend seen throughout 2011, when spot market rates rose 7.4 percent overall compared to 2010.

Rates followed seasonal patterns for January, which is typically a slow month for trucking freight volume and rates. For dry vans, the predominant equipment type, rates slipped 1.5 percent compared to December. Flatbed rates declined 2.4 percent and reefer rates slipped 6.5 percent month-over-month. These rates are derived from TransCore’s Truckload Rate Index, and do not include fuel surcharges. Spot market rates are paid by brokers and 3PLs to the carrier.

About TransCore Freight Solutions:

TransCore Freight Solutions serves brokers, carriers, owner-operators and shippers in the United States and Canada with best-in-class products. Load boards include Loadlink in Canada and TransCore 3sixty powered by the DAT Network in the United States, which has set the industry standard for the spot freight marketplace since 1978. TransCore provides Keypoint transportation software, the most popular broker logistics software, fleet compliance, distribution and intermodal services, as well as TransCore CarrierWatch, automated carrier safety and insurance monitoring and TransCore Truckload Rate Index for spot and contract markets rates. TransCore’s asset tracking and in-cab communications solutions feature the industry’s fastest response times and state-of-the-art satellite networking.

TransCoreBarbara Catlin, 972-740-7150Barbara.Catlin@TransCore.com

Source: TransCore

DALLAS, Feb. 13, 2012 (GLOBE NEWSWIRE) -- More than six million American adults suffer from heart failure. But, while the prevalence of this disease has increased over time, there are signs that deaths from it have not and hospitalization rates may be stabilizing as well. Healthcare professionals say this is good news and the future looks even more promising.

"Despite the increasing number of people affected, the prognosis for patients with heart failure has steadily improved," said Gregg C. Fonarow, M.D, chairman of American Heart Association Hospital Accreditation Science Committee and professor of cardiovascular medicine of the University of California, Los Angeles. "This is testament in part to better therapies and systems for treating this condition. There has been so much research and advancement in this area that what used to be a very dismal diagnosis is no longer the norm. Used appropriately, available medical and device therapies are even more effective than originally believed and best practices of care have now been shown to save lives."

Heart failure is a chronic, progressive condition in which the heart muscle is unable to pump enough blood through the heart to meet the body's needs for blood and oxygen. Basically, the heart can't keep up with its workload.

The weakened heart can't supply the cells with enough blood. This results in fatigue and shortness of breath. Everyday activities such as walking, climbing stairs or carrying groceries can become difficult.

Heart failure is caused by damage to the heart that impairs its ability to function. However, even for the patient with chronic heart muscle weakness, a significant amount of heart function can now be restored by the correct use of heart failure medication and devices.

"Even for our patients with advanced disease, there are so many more options now available to us," said Clyde Yancy, M.D., past president of the American Heart Association and chief of the Division of Cardiology and the Magerstadt Professor at Northwestern University Feinberg School of Medicine in Chicago. "The use of mechanical support such as artificial heart pumping devices, has become remarkable. We can sustain patients long enough to not only allow for heart transplantation but also to serve as definitive therapy and even more provocatively to support recovery of heart muscle function even when seemingly dramatic changes have taken place."

Along with advanced technologies, improvements in quality of care are also making a difference in heart failure outcomes.

Studies have shown that heart failure patients treated with American Heart Association/American College of Cardiology guideline-recommended therapies are more likely to survive over the next two years. Every 10 percent improvement in the use of guideline-recommended therapies has been associated with a 13 percent lower risk of death among heart failure patients over the next two years. (Fonarow G, et al. Associations between outpatient heart failure process-of-care measures and mortality. Circulation. 2011;123:1601-1610)

Recent studies also show that patients treated in hospitals participating in the American Heart Association's Get With The Guidelines®-Heart Failure program receive higher quality of care and may experience better outcomes.

Hospital readmissions after treatment for heart failure have been a growing and costly issue in the past. But Fonarow said greater use of guideline-recommended therapies, improved care transitions and enhanced participation in quality improvement efforts are key to turning this around.

"It's important for a heart failure patient ― and their caregivers ― to be aware of what's going on with their body during recovery and beyond and to quickly deal with any new or fluctuating symptoms," he said. "Sometimes a quick and early call to your healthcare provider can make a big difference in getting you back on track rather than dismissing those symptoms until they require more drastic treatment, including hospitalization."

That's a goal of one of the American Heart Association's latest quality campaigns ― Target: Heart Failure. The initiative provides healthcare professionals with content-rich resources and materials designed to help them improve heart failure awareness, prevention, treatment and recovery.

Yancy said many people with heart failure are actually able to lead a full, enjoyable life when the condition is managed with correct medications and devices and with healthy lifestyle changes. Successful treatment depends on the willingness of patients and caregivers to get involved in managing the condition.

"But what's most encouraging to me is what we've learned about the prevention of heart failure," he said. "The effective treatment of high blood pressure and reduction of known risk factors for coronary artery disease will indeed prevent heart failure from occurring. That's the best treatment ― to never have heart failure."

"The present environment for heart failure is much better than ever before and the future holds promises that will truly remove 'failure' from our description of this illness," Fonarow said.

The American Heart Association/American Stroke Association receives funding mostly from individuals. Foundations and corporations donate as well, and fund specific programs and events. Strict policies are enforced to prevent these relationships from influencing the association's science content. Financial information for the American Heart Association, including a list of contributions from pharmaceutical companies and device manufacturers, is available at www.heart.org/corporatefunding

QI12 – 1000 (HF-awareness)

Additional Resources:

• To learn more about heart failure, visit www.heart.org/heartfailure.
• For an important resource to use in talking to your doctor about heart failure: http://www.heart.org/HEARTORG/Conditions/HeartFailure/HeartFailureToolsResources/Heart-Failure-Questions-to-Ask-Your-Doctor_UCM_306372_Article.jsp
• As a caregiver of a loved one with heart failure, your role is very important ― and it's just as important for you to take good care of yourself. There are many resources to help you at www.heart.org/caregiver.
• To learn more about Target: Heart Failure and Get With The Guidelines, visit www.heart.org/quality.
• To watch an animation of heart failure compared to the healthy heart: http://www.medmovie.com/mmdatabase/MediaPlayer.aspx?ClientID=69&TopicID=563

The American Heart Association logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=9940

CONTACT:  Media Contact:
          Cathy Lewis - (214) 706-1324; cathy.lewis@heart.org

          For Public Inquiries: (800)-AHA-USA1 (242-8721)

GRENOBLE, France & DELFT, The Netherlands--(BUSINESS WIRE)--

• Demonstrated resolution meets the industry requirement for the next generation 14 nm and 10 nm Logic technology nodes
• Continuation of IMAGINE programme by installing MAPPER’s first Matrix pre-production tool

CEA-Leti, the French Research and Technology Institute, reports significant progress on the capabilities of the massively parallel direct write technology developed by Delft, The Netherlands based MAPPER Lithography. The major achievement has been obtained in resolution: 22nm dense lines and spaces and 22 nm dense contact holes in positive chemically amplified resist have been successfully resolved. This demonstrated resolution also meets the industry requirement for the next generation 14 nm and 10 nm Logic technology nodes. The reported progress is the outcome of the 5th Operational Review of the IMAGINE program hosted by CEA-Leti January 24th – 26th. Furthermore CEA-Leti and Mapper announce the three year continuation of the IMAGINE programme through the future installation at CEA-Leti of one of MAPPER’s first pre-production Matrix systems, offering global players to assess maskless lithography technology in a real manufacturing environment.

The industry/research multi-partner program IMAGINE is an initially three-year project led by CEA-Leti, and includes leading semiconductor manufacturers TSMC and STMicroelectronics. More than 50 representatives from 13 different companies participating in the IMAGINE project, attended the Operation Review event. In this event CEA-Leti reported latest achievements obtained on MAPPER’s pre-alpha platform installed in its cleanroom since mid-2009, including a stitching demonstration.

“This result represents a state-of-the-art demonstration obtained thanks to the collaboration between partners. It demonstrates the capability of this technology that represents a real alternative for advanced semiconductor manufacturing” comments Laurent Pain, coordinator of the IMAGINE program and manager of the CEA-Leti lithography laboratory.

Bert Jan Kampherbeek, MAPPER’s CEO says:”This breakthrough marks another important step towards the introduction of our innovative tool for semiconductor manufacturing. In 2012 MAPPER will complete its Matrix pre-production platform with initially a 1 wafer per hour throughput capability and scalable to 10 wafers per hour. Given the great results we have obtained at CEA-Leti thus far, we are proud to announce that one of the first Matrix systems will be installed at CEA-Leti to enable the continuation of the IMAGINE programme.”

Laurent Malier, CEA-Leti CEO says: “The outcomes of IMAGINE reflect the involvement of CEA-Leti to push and promote this very promising lithography solution. We are already preparing the future together with MAPPER with the arrival of the first pre-production tool in our premise. By continuing the IMAGINE program for another three years, we will continue to answer to the increasing interest showed by industry”

About the IMAGINE programme

The IMAGINE project is an initially three-year project led by CEA-Leti, evaluating a maskless lithography infrastructure and the use of MAPPER Lithography tools for high throughput. The multiple e-beam-lithography program covers a global approach to the technology, including tool assessment, patterning and process integration, data handling, prototyping and cost analysis. The MAPPER platform is the core technology on which the IMAGINE program is built. This program provides the world’s major chip manufacturers with the opportunity to assess maskless lithography technology in a real manufacturing environment. In addition, it will develop and qualify the complete infrastructure, from data preparation to process integration, in preparation for its industrial introduction.

Participants in the IMAGINE project include leading semiconductor manufacturers TSMC and STMicroelectronics and a number of technical solutions suppliers like Nissan Chemical, TOK, Dow, JSR Micro, Synopsys, Mentor Graphics, Sokudo, Tel and Aselta.

About CEA-Leti

Leti is an institute of CEA, a French research-and-technology organization with activities in energy, IT, healthcare, defence and security. Leti is focused on creating value and innovation through technology transfer to its industrial partners. It specializes in nanotechnologies and their applications, from wireless devices and systems, to biology, healthcare and photonics. NEMS and MEMS are at the core of its activities. An anchor of the MINATEC campus, CEA-Leti operates 8,000-m² of state-of-the-art clean room space on 200mm and 300mm wafer platforms. It employs 1,400 scientists and engineers and hosts more than 190 Ph.D. students and 200 assignees from partner companies. CEA-Leti owns more than 1,700 patent families. For more information, visit www.leti.fr.

About MAPPER Lithography

MAPPER Lithography, based in Delft, The Netherlands, near Delft University of Technology, develops a ground breaking maskless lithography infrastructure for the semi conductor industry. These tools utilize an innovative multiple e-beam technology, with which next generation semi-conductors can be manufactured in a more cost effective fashion. It makes the tradionally used mask redundant and combines high resolution and high productivity. MAPPER has a headcount of 190.

Press ContactsCEA-LetiThierry Bosc+33 4 38 78 31 95thierry.bosc@cea.frorMAPPER LithographyBert Jan Kampherbeek, CEOTel +31 15888 0250orCEA-LetiSerge Tedesco - Lithography program manager+33 4 38 78 49 89serge.tedesco@cea.frorWeber ShandwickEric Chauvelot/Robert Ba+33 1 47 59 56 57 / 38 75echauvelot@webershandwick.comrba@webershandwick.com

Source: CEA-Leti

CALGARY, ALBERTA--(Marketwire - Feb. 13, 2012) - Red Rock Energy Inc. (TSX VENTURE:RRK) ("Red Rock" or the "Company") announced today that it has completed the initial phases of its three-well workover program in North Eastern British Columbia. Conducted through its wholly owned subsidiary Red Rock Projects Inc., this program is designed to test two oil bearing formations. Operations commenced in early January 2012 with activity on the planned well recompletions and production test.

Initial results from the well that was production tested are encouraging. The well swabbed 31 degrees API oil for a period of five consecutive days producing at a stabilized rate of 48 bopd and steady water cut of 50%. Currently the well has been shut-in for pressure build-up and production options are being evaluated for a nearby tie-in. This well has been designated as a discovery well by the British Columbia Oil and Gas commission which entitles it to a royalty holiday for 3 years. Well data from wells in the area indicates that this oil pool has the potential for multiple drilling locations with significantly thicker oil pay on additional lands now controlled by Red Rock. Additionally Red Rock's technical team continues to evaluate the potential of utilizing horizontal drilling applications to maximize oil recovery from the tested formation and the potential of secondary targets in the region.

To date Red Rock has received preliminary results from the workover programs from the other two wells and will commence further testing of these wells pending the availability of equipment and other resources. Upon completion of the above mentioned programs, Red Rock will have successfully tested all three wells with the intent of moving each of the wells into the next phase of development and production pending results. Moving forward, Red Rock continues to actively compile, review, integrate and interpret data with the goal being to identify multi-well oil prospects.

Through Red Rock Projects Inc., the Company owns or controls a working 100% interest in 13 of 15 sections of land in the region. All sections were procured for their light oil potential utilizing a geological model that has been substantiated by several analogies.

In releasing the first test results of the Company's new oil exploration operations, Sandy Loutitt, President of Red Rock, stated: "We are extremely pleased with the results obtained from these projects. The data from the well that was production tested were very encouraging, and the initial results obtained from the two wells with workover programs partially completed positions us well to move ahead with further testing. Most importantly, the conclusions from these operations as a whole confirm in large measure that the potential of these oil-bearing zones is indeed very high, and we look forward to exploring the numerous other targets which exist on Red Rock lands."

READER ADVISORY

Statements in this press release may contain forward-looking information including expectations of future production, operating costs, commodity prices, administrative costs, commodity price risk management activity, acquisitions and dispositions, capital spending, access to credit facilities, income taxes, regulatory changes, and other components of cash flow and earnings. The reader is cautioned that assumptions used in the preparation of such information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the company. These risks include, but are not limited to, the risks associated with the mining industry, commodity prices and exchange rate changes. Industry related risks could include, but are not limited to, operational risks in exploration, development and production, delays or changes in plans, risks associated to the uncertainty of reserve estimates, health and safety risks and the uncertainty of estimates and projections of production, costs and expenses. The reader is cautioned not to place undue reliance on this forward-looking information.

Neither the TSX Venture Exchange nor is Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

FOR FURTHER INFORMATION PLEASE CONTACT:
        Red Rock Energy Inc.
        Sandy Loutitt
        President
        403-685-1047

        Red Rock Energy Inc.
        Rick Couronne
        Investor Relations
        403-685-1047
        www.redrockenergy.ca

Source: Red Rock Energy Inc.